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The	fungal	pathogen	Candida albicans	has	a	multilayered	cell	wall	composed	of	an	outer	layer	of	proteins	
glycosylated	with	N-	or	O-linked	mannosyl	residues	and	an	inner	skeletal	layer	of	β-glucans	and	chitin.	We	
demonstrate	that	cytokine	production	by	human	mononuclear	cells	or	murine	macrophages	was	markedly	
reduced	when	stimulated	by	C. albicans	mutants	defective	in	mannosylation.	Recognition	of	mannosyl	residues	
was	mediated	by	mannose	receptor	binding	to	N-linked	mannosyl	residues	and	by	TLR4	binding	to	O-linked	
mannosyl	residues.	Residual	cytokine	production	was	mediated	by	recognition	of	β-glucan	by	the	dectin-1/
TLR2	receptor	complex.	C. albicans	mutants	with	a	cell	wall	defective	in	mannosyl	residues	were	less	virulent	
in	experimental	disseminated	candidiasis	and	elicited	reduced	cytokine	production	in	vivo.	We	concluded	
that	recognition	of	C. albicans	by	monocytes/macrophages	is	mediated	by	3	recognition	systems	of	differing	
importance,	each	of	which	senses	specific	layers	of	the	C. albicans	cell	wall.
Introduction
Invasive Candida albicans infections are a serious clinical threat in 
patients who are immunosuppressed or undergo major surgical 
procedures. Mortality associated with disseminated candidiasis 
can be as high as 30–40%, despite the availability of new anti-
fungal drugs (1, 2). Host defense against systemic candidiasis 
relies mainly on the ingestion and elimination of C. albicans 
by cells of the innate immune system, especially neutrophils, 
monocytes, and macrophages (3–6). After activation of these 
leukocyte populations by C. albicans, release of proinflamma-
tory cytokines such as TNF-α, IL-1β, IL-6, and IFN-γ is the first 
step in the activation of anticandidal innate immune responses. 
Proinflammatory cytokines activate neutrophils and macro-
phages to phagocytose the fungus and to release toxic oxygen 
and nitrogen radicals, thus eliminating the invading pathogen 
(7, 8). The crucial role of proinflammatory cytokines for the 
host defense against C. albicans has been demonstrated by the 
increased susceptibility to candidiasis of knockout mice lacking 
these cytokines (9, 10). In contrast, antiinflammatory cytokines 
such as IL-4 and IL-10 have immunosuppressive effects (11). It is 
currently believed that the balance between pro- and antiinflam-
matory cytokine production is decisive in determining whether 
the host defense system is overwhelmed or able to eliminate the 
fungal pathogens (12).
Stimulation of proinflammatory cytokine production and the 
activation of innate immunity depend on accurate recognition of 
an invading pathogen. The basic strategy for recognizing patho-
gens by the cells of the innate immunity system consists of non-
clonal recognition of conserved structures of microorganisms, 
called pathogen-associated molecular patterns (PAMPs), which are 
not present in mammalian cells. Several classes of pattern-recogni-
tion receptors (PRRs) recognize the various PAMPs, of which TLRs 
and C-type lectin receptors are probably the most important (13). 
We and others have recently identified TLR2 and TLR4 as impor-
tant PRRs for C. albicans (14–17). The mannose receptor (MR) has 
also been implicated in the stimulation of cytokine production by 
C. albicans (18), and we have recently demonstrated that the C-type 
lectin DC-specific ICAM3-grabbing nonintegrin (DC-SIGN) medi-
ates the uptake of C. albicans by dendritic cells (19).
The outer layer of the cell wall of C. albicans is enriched with 
mannoproteins, which represent 30–40% of the cell wall dry 
weight (20). The inner layer is composed of chitin and β1,3- and 
β1,6-glucan. Earlier studies have suggested that mannosylated 
proteins of C. albicans induce cytokine production (21), and C. 
albicans mannan reportedly interacts with TLR4 (22). It has been 
suggested that phospholipomannan of C. albicans is recognized 
by TLR2 and induces proinflammatory cytokine production 
(23), whereas β-glucans were recognized by a complex of TLR2 
and dectin-1 (24, 25). However, the relative contribution of these 
PAMPs and their respective receptors to cytokine stimulation by 
C. albicans is not known.
Despite the progress in understanding the interaction of some 
of the fungal PAMPs with leukocyte receptors, there is no inte-
grated view of the mechanisms by which the immune system 
Nonstandard	abbreviations	used: MNC, mononuclear cell; MR, mannose receptor; 
PAMP, pathogen-associated molecular pattern; PRR, pattern-recognition receptor; 
TEM, transmission electron microscopy.
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recognizes C. albicans. We hypothesized that recognition of C. 
albicans is a multiple-level process involving specific receptor sys-
tems that recognize each layer of the fungal cell wall. The skel-
eton of the C. albicans cell wall is mainly formed by chitin and 
β1,3- and β1,6-glucans, whereas the outer cell wall is enriched 
with proteins that are modified with both long-chain and high-
ly branched N-linked mannosyl residues as well as short linear 
chains of O-linked mannosyl residues. Using a range of isogenic 
glycosylation mutants (26–29), ligand-specific blocking experi-
ments, and PAMP receptor knockout mice, we show that rec-
ognition of C. albicans by monocytes/macrophages is a complex 
process involving multiple recognition systems and that these 
receptor systems recognize sequentially the various layers of the 
outer portion of the fungal cell wall.
Results
Cell wall mutants of C. albicans. We have taken a genetic approach 
to investigate how immune cells recognize a fungal pathogen. 
We have used well-defined stable isogenic mutants of C. albicans 
depleted in specific cell wall components to investigate cytokine 
responses of monocytes. The och1 mutant was defective in outer, 
branched N-linked glycans, and transmission electron micros-
copy (TEM) revealed a thicker cell wall lacking a fibrillar man-
noprotein layer (ref. 29 and compare Figure 1B with Figure 1A). 
The mnt1 mnt2 mutant lacks the 4 terminal O-linked α1,2-man-
nosyl residues, but had normal N-mannan (24) and a fibrillar 
outer wall surface (Figure 1C). The pmr1 mutant has defects in 
both N- and O-linked mannosylation, and had a thinner and less 
fibrillar cell wall than the control strain (Figure 1D). The mnn4 
mutant lacks phosphomannan (25) and was indistinguishable 
by TEM from that of wild-type cells (Figure 1E). Therefore this 
set of mutants provided a unique molecular biological tool to 
dissect the immune responses of monocytes.
Mannan stimulates cytokines in a TLR4- and MyD88-dependent man-
ner. Purified mannan (a mixture of both N- and O-linked oligosac-
charides) from C. albicans stimulated production of TNF and IL-6 
in both human mononuclear cells (MNCs) and murine peritoneal 
macrophages (Figure 2A). The induction of TNF in murine peri-
toneal macrophages was significantly decreased in mice deficient 
in MyD88, demonstrating that a TLR-dependent mechanism was 
involved in this stimulation (Figure 2B). Indeed, the diminished 
stimulation of macrophages harvested from TLR4-defective ScCr 
mice demonstrated a TLR4-dependent stimulation of TNF by C. albi-
cans mannan, whereas TLR2–/– mice produced normal amounts of 
cytokines (Figure 2B). Because purified mannan is a relatively weak 
cytokine stimulus compared with C. albicans, we investigated wheth-
er purified mannan would inhibit C. albicans–induced cytokine pro-
duction by occupying the mannan-binding sites on leukocytes. The 
presence of purified mannan significantly inhibited the production 
of TNF and IL-6 stimulated by C. albicans, demonstrating that man-
nan-binding sites are important for the induction of cytokines by 
the yeast (Figure 2C). In control experiments, mannan had no effect 
on LPS-induced cytokine production (data not shown). Therefore, 
fungal mannan stimulated cytokine production, and pretreatment 
with purified mannan blocked the cytokine response induced by C. 
albicans yeast cells, suggesting an important role of mannan recogni-
tion receptors for the stimulation of cytokines by the fungus.
The role of mannosyl residues for cytokine stimulation. The role of 
global mannosylation of mannoproteins for the stimulation 
of cytokines by human MNCs was investigated using a pmr1 
Figure 1
Cell wall morphology in the C. albicans strains used in this study. (A–E) TEM micrographs. (A) Wild-type strain NGY152 [CAI-4 plus CIp10 vector]. 
(B) och1 null (strain NGY357; ref. 26) or doxycycline-regulated conditional (strain NGY361; ref. 29) mutants, which are defective in the branched 
outer N-linked mannosyl chains. (C) mnt1 mnt2 mutant (strain NGY337; ref. 27), which lacks 4 terminal O-linked α1,2-mannosyl residues. (D) pmr1 
mutant (strain NGY355; ref. 26), which has gross defects in mannosylation, characterized by absence of phosphomannan and reduced O-linked 
and N-linked glycans. (E) mnn4 mutant (strain CDH15; ref. 28), which lacks phosphomannan. Scale bar: 100 nm. (F and G) Structure of the N- (F) 
and O-linked (G) glycans and the site of action of deleted gene products. Man, mannosyl; β-GlcNAc, β N-acetylglucosamine.
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C. albicans mutant (26). The pmr1 mutant induced significantly 
less TNF and IL-6 than did the control strain in which PMR1 was 
reintroduced (Figure 2D). Therefore, normal cytokine stimulation 
is dependent on mannosylation of the cell wall.
To investigate the specific roles of N- and O-linked mannosyl 
residues for stimulation of cytokines by C. albicans, we compared 
the stimulation of cytokines by C. albicans strains defective in 
N-linked mannosyl residues (och1), O-linked mannosyl residues 
(mnt1 mnt2), and mannosylphosphate (mnn4) in human MNCs. 
The absence of O-linked mannosyl residues diminished cytokine 
release by 30% in the case of IFN-γ, whereas the production of 
TNF was only 15–20% lower (Figure 3, A and C). In contrast, the 
absence of N-linked mannosyl residues reduced cytokine release 
by 70% (Figure 3, A and C). No role of phosphomannan was 
observed for the induction of cytokine release (Figure 3). Phos-
phomannan is synthesized preferentially in stationary phase 
cells; however, no differences were found in cytokine induction 
by exponential or stationary phase yeast cells (data not shown). 
An mnn4 mutant in a serotype B background (30) was also unaf-
fected in its cytokine-inducing properties (data not shown). 
Similar conclusions were drawn when a time course of the stim-
ulation was performed (Figure 3, C and D). IL-6 release by the 
various mannosylation mutants displayed a production pattern 
identical to that of TNF (data not shown).
Normal cytokine release was recovered 
in strains in which the deleted genes were 
reintegrated into their respective mutants 
(Figure 4, A and C). In strain TET-OCH1, 
the expression of OCH1 was regulated by 
placing the OCH1 open reading frame 
under the control of a promoter that was 
regulatable by tetracyclines. Growth in 
20 μg/ml doxycycline switched off expres-
sion of OCH1 and resulted in a reduction 
of cytokine production to a similar level 
as the och1 mutant. Growth of TET-OCH1 
in the absence of doxycycline resulted in 
expression of OCH1 and induced cytokine 
production similar to that of the wild-
type strain CAI-4 (Figure 4B).
Similar results were obtained in experi-
ments with live C. albicans cells. The live 
och1 strain induced only 29% of the TNF 
production induced by the control strain 
(0.36 ± 0.11 ng/ml versus 1.21 ± 0.23 ng/ml; 
P < 0.05), while the live mnt1 mnt2 strain 
stimulated 78% of the control TNF pro-
duction (0.94 ± 0.21 ng/ml; P < 0.05). 
In contrast, PBMC stimulated with the 
mnn4 strain released normal amounts 
of TNF (1.79 ± 0.64 pg/ml; P = NS). A 
similar stimulation pattern was found 
for other cytokines (data not shown). 
Using live fungal cells, we assessed the 
morphology of the fungal elements 
during the assay (37°C incubation in 
RPMI medium in the absence of plasma 
or serum). Whereas formation of pseu-
dohyphae was common, no fully devel-
oped hyphae were formed. Importantly, 
there were no differences in hyphal formation among the various 
mutant strains and the control strain during the incubation.
Recognition of O-linked and N-linked mannosyl residues by TLR4 and 
MR. Specific anti-TLR4 and anti-MR blocking antibodies were 
used to investigate which PRR was involved in the recognition of 
mannosyl residues of the C. albicans cell wall. Blockade of either 
TLR4 or MR of human MNCs inhibited TNF production stimu-
lated by the C. albicans wild-type strain NGY152. In contrast, dif-
ferential blockade of cytokine release was observed in the case 
of the och1 and mnt1 mnt2 mutant strains. The TNF released by 
the PBMCs stimulated with the N-linked mannosylation-defec-
tive och1 mutant was inhibited by anti-TLR4, but not by the anti-
MR antibody (Figure 5A), demonstrating that the MR recognizes 
N-linked mannosyl residues. The opposite was true for TNF 
stimulation by the O-linked mannosylation defective mnt1 mnt2 
mutant, which was inhibited by anti-MR antibodies but not by 
anti-TLR4 antibodies, suggesting that TLR4 recognizes O-linked 
mannosyl residues (Figure 5A). This conclusion was confirmed 
in TLR4-deficient mice, which displayed lower TNF production 
after stimulation with CAI-4 and och1 strains but not after stimu-
lation with the mnt1 mnt2 mutant (Figure 5B).
The role of β-glucan–dectin-1 interaction for cytokine stimulation. Interac-
tion of β-glucans with dectin-1/TLR2 complexes has been shown to 
induce cytokine production, and DC-SIGN is an additional C-type 
Figure 2
The role of mannan for the cytokine stimulation by C. albicans. (A) Human MNCs or peritoneal 
macrophages from C57BL/6J mice were stimulated for 24 hours at 37°C with 50 μg/ml purified 
mannan from C. albicans. (B) Peritoneal macrophages from wild-type mice and mice deficient in 
MyD88, TLR2, or TLR4 were stimulated with mannan. TNF and IL-6 concentrations were mea-
sured in the supernatants by specific RIA and ELISA, respectively. Results are pooled data from 
2 separate experiments with a total of 10 mice per group. (C) Purified mannan was preincubated 
for 1 hour at 37°C with human MNCs before stimulation with 1 × 106 yeast cells/ml. Supernatants 
were collected after additional incubation for 24 hours, and TNF and IL-6 were measured. (D) 
Human MNCs were stimulated for 24 hours at 37°C with whole cells of either wild-type C. albicans 
(strain NGY152; ref. 26), a mutant defective in the Golgi transporter pmr1 (strain NGY355; ref. 26), 
or a control strain in which a wild-type copy of PMR1 was introduced into the pmr1 mutant (strain 
NGY356; ref. 26). TNF and IL-6 concentrations were assessed by RIA and ELISA, respectively. 
Results (mean ± SD) are pooled triplicate data from 2 separate experiments with a total of 8 volun-
teers per group. *P < 0.05 versus wild-type.
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lectin receptor that is able to recognize C. albicans. We hypothesized 
that interaction of C. albicans with either of these receptors may 
account for the residual cytokine production induced in the absence 
of the mannosyl residues. Accordingly, we used combinations of 
C. albicans mutant strains and receptor blockade and assessed TNF 
release by the och1 mutant in TLR4–/– mice and by the mnt1 mnt2 
strain in the presence of anti-MR antibodies. In these 2 situations, 
the signals induced by both N-linked mannosyl/MR and O-linked 
mannosyl/TLR4 complexes were absent. The residual cytokine pro-
duction stimulated by C. albicans in these 2 experimental conditions 
was completely blocked by laminarin, a ligand of dectin-1 that is 
rich in β1,3-glucan (Figure 6). In contrast, no role for DC-SIGN 
could be demonstrated using specific blocking antibodies (data not 
shown). Interestingly, when dectin-1–blocking experiments were 
performed with either heat-killed or live C. albicans microorgan-
isms, laminarin had a much stronger inhibitory effect on cytokines 
Figure 3
The role of N- and O-linked mannosyl 
residues for cytokine stimulation by 
C. albicans. MNCs were stimulated 
for various time points with the various 
C. albicans strains: the wild-type parent 
NGY152 strain; the och1 mutant (strain 
NGY357; ref. 29), defective in N-linked 
mannan; the mnt1 mnt2 mutant (strain 
NGY337; ref. 27), defective in O-linked 
mannan; and the mnn4 mutant (strain 
CDH15; ref. 28), defective in phospho-
mannan. (A and C) C. albicans concen-
tration-dependent stimulation curves for 
TNF (A) and IFN-γ (C) after stimulation 
for 24 hours. (B and D) Time-dependent 
stimulation curves for the 2 cytokines 
when MNCs were stimulated with the 
various C. albicans strains. Results 
(mean ± SD) are pooled triplicate data 
from 2 separate experiments with a total 
of 8 volunteers per group. *P < 0.05; 
**P < 0.01 versus wild-type.
Figure 4
Reintegration of the defective genes restores cytokine production. (A) MNCs were stimulated with the parent NGY152 strain, the N-linked man-
nosyl-defective C. albicans strain (och1; strain NGY357; ref. 29), and the complemented reintegrant och1/och1/OCH1 strain (strain NGY358). 
(B) Stimulation was also performed with the conditional doxycycline-dependent mutant (pTET/och1; strain NGY361; ref. 29) in both the absence 
and the presence of doxycycline (doxy). (C) Comparison of the mnt1 mnt2 mutant (strain NGY337; ref. 27), defective in O-linked mannosyl resi-
dues, with the mnt1 mnt2 + MNT1 reintegrant strain (strain NGY335; ref. 27). After 24 hours’ stimulation at 37°C, supernatants were collected, 
and cytokines were determined by RIA or ELISA. Results (mean ± SD) are pooled triplicate data from 2 separate experiments with a total of 8 
volunteers per group. *P < 0.05; **P < 0.01 versus wild-type.
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induced by heat-killed C. albicans yeasts compared with live fungi 
(data not shown). This finding strongly sustains the recent findings 
of Gantner et al., who reported that the β-glucans of the cell wall in 
live cells are shielded from recognition by the mannan layers but 
become exposed in heat-killed C. albicans (31).
The role of mannosyl residues in the virulence of C. albicans. Published 
experiments from our groups have established the role of mannosyl 
residues in the virulence of C. albicans. We have shown that the och1, 
pmr1, and mnt1 mnt2 strains are attenuated in virulence in a mouse 
model (26, 27), but that the mnn4 mutant is unaffected in virulence 
(28). We extended this in the present study by characterizing the 
course of disseminated candidiasis and cytokine production in mice 
infected with the och1 C. albicans strain. Compared with the wild-type 
strain, the och1 strain induced significantly less mortality in a model 
of disseminated candidiasis in mice (Figure 7A) and had a reduced 
fungal load in the organs of the mice (Figure 7B). However, viable 
cells were still present in kidneys with little sign of disease. Virulence 
was fully recovered in the control strain that contained a reintegrat-
ed copy of OCH1 (Figure 7). These virulence parameters were paral-
leled by significantly decreased cytokine levels in the kidneys of the 
mice infected with the och1 C. albicans mutant (Figure 7C).
Discussion
In the present study, we have shown that 3 components of the cell 
wall of a pathogenic fungus, N-linked mannans, O-linked man-
nans, and β-glucans, are involved in the recognition by monocytes/
macrophages and for the subsequent induction of pro- and anti-
inflammatory cytokine release. To investigate the role of cell 
wall mannosyl groups for the recognition of C. albicans, we used 
isogenic mutant strains of C. albicans with specific defects in the 
mannosylation of cell wall proteins. A gross defect in protein man-
nosylation was investigated using C. albicans Pmr1p, which encodes 
a Mn2+/Ca2+ transporter necessary for the activity of several Golgi-
bound mannosyl transferases and shows defects in both N-linked 
and O-linked mannosylation (29). The role of phosphoman-
nan was investigated in the mnn4 mutant (28), while the role of 
O-linked mannosylation was assessed using a mnt1 mnt2 mutant 
strain lacking 2 partially redundant α1,2-mannosyl transferases 
that are required to add the second and third mannose residues to 
a linear oligomannoside (27). Finally, the effects of N-linked man-
nosylation were investigated in the och1 C. albicans strain, which 
lacks an α1,6-mannosyl transferase that is required for initiation	of 
the synthesis of the branched outer mannan chains (29).
We demonstrated that N-linked and O-linked mannosyl groups 
of glycoproteins of the outer surface of the cell wall were respon-
sible for most of the cytokine-stimulating activity by the yeast 
Figure 5
Differential recognition of O- and N-linked mannosyl residues by TLR4 
and MR. (A) Human MNCs were stimulated with the various C. albicans 
strains — the parent NGY152 strain; the och1 mutant (strain NGY357; 
ref. 29), defective in N-linked mannosylation; and the mnt1 mnt2 mutant 
(strain NGY337; ref. 27), defective in O-linked mannosylation — in the 
presence of monoclonal antibodies against TLR4 or MR or a isotype-
matched control antibody. After 24 hours’ stimulation at 37°C, super-
natants were collected, and TNF concentration was measured by RIA. 
Results are pooled triplicate data from 2 separate experiments with a 
total of 8 volunteers per group. (B) Murine peritoneal macrophages from 
TLR4+/+ C57BL/10J and TLR4–/– ScCr mice were stimulated with the var-
ious C. albicans strains: NGY152, the och1 mutant (NGY357; ref. 29), 
and the mnt1 mnt2 mutant (NGY337; ref. 27). After 24 hours’ stimulation 
at 37°C, supernatants were collected, and TNF levels were determined 
by RIA. Results (mean ± SD) are pooled data from 2 separate experi-
ments with a total of 10 mice per group. *P < 0.05 versus stimulation in 
the presence of control antibodies (A) or versus TLR4+/+ mice (B).
Figure 6
The role of β-glucan/dectin-1 interaction for cytokine stimulation by 
C. albicans. The role of β-glucan/dectin-1 interaction for C. albicans–
induced TNF was investigated using 2 approaches with combinations 
of mutant C. albicans strains and receptor blockade: (A) stimulation 
with the och1 NGY357 strain (29) in TLR4–/– mice and (B) stimula-
tion with mnt1 mnt2 NGY337 strain (27) in the presence of anti-MR 
antibodies in human MNCs. In both situations, the signals induced by 
N-linked mannosyl/MR and O-linked mannosyl/TLR4 complexes were 
deficient. The residual cytokine production stimulated by C. albicans 
in these 2 experimental conditions was completely blocked by lami-
narin, a ligand of dectin-1. Results (mean ± SD) are pooled data from 2 
separate experiments with a total of 10 mice per group (A) or 8 human 
volunteers (B). *P < 0.05; **P < 0.01; ***P < 0.001 versus wild-type.
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cell. This was achieved through the specific interaction of the 
N-linked mannosyl residues with MR and of the O-linked man-
nosyl residues with TLR4. However, the mannosylphosphate 
fraction of the N-linked glycan played practically no role in this 
process. The residual cytokine production stimulated by C. albi-
cans strains lacking mannosyl residues was mediated by the inter-
action of β-glucan with dectin-1, probably in cooperation with 
TLR2, as discussed below. Thus 3 C. albicans PAMPs cooperate in 
the activation of the innate immune response, and recognition is 
a multilevel process involving cooperation between TLRs (TLR4, 
TLR2) and lectin receptors (MR, dectin-1).
Mannoproteins, β1,2-oligomannosides, phospholipomannan, 
and β-glucans have all been implicated individually in cytokine 
stimulation induced by C. albicans (21, 32–34). The β1,3-glucans 
are mainly situated in the interior layer of the cell wall of C. albi-
cans, and living yeast cells do not display large amounts of glu-
cans at their surface. β-glucans become accessible only when the 
surface mannan coat is removed or damaged by killing, as is the 
case in zymosan particles that are chemically denuded of man-
nan (35), or at the site of budding scars in C. albicans yeasts, which 
are absent from hyphal cells (31). In contrast, α- and β-linked 
mannosyl residues are abundant at the surface of the fungus. 
We found that α-linked mannan is critically involved in cytokine 
stimulation. The β-linked mannosyl residues are present in the 
acid-labile and acid-stable fractions of N-linked mannans in sero-
type A strains, in the acid-labile fraction of serotype B strains, 
and in the structure of phospholipomannan (36). However, 
cytokine induction was not affected in assays with mnn4 mutants 
in either serotype A or serotype B backgrounds (29). The cell wall 
is therefore a multilayered structure, and it is the external, heav-
ily α-linked, mannosylated portion of the cell wall that is most 
strongly recognized by monocytes.
Mannoproteins have been previously implicated as important 
cytokine stimuli (21) — our study provides a refined molecular 
description of this process. The results of our 3 independent 
approaches support this conclusion. First, we showed that puri-
fied mannan isolated from C. albicans stimulated cytokine pro-
duction in a manner dependent partly on MyD88, an intracellular 
TLR adaptor molecule (37), and on TLR4. This extends previous 
studies that also suggested TLR4-dependent cytokine production 
by mannan (22). Second, we demonstrated that mannan-bind-
ing sites on the surface of leukocytes were important for recog-
nition of the yeast cell surface (5). Third, mutants lacking N- or 
O-linked mannosyl residues were markedly affected in their abil-
ity to induce cytokines in monocytes.
We demonstrated that a global defect in the mannosylation of 
cell wall mannoproteins due to in the absence of the pmr1 Golgi 
transporter resulted in strongly reduced cytokine induction. Per-
haps surprisingly, considering the reported immunostimulatory 
effects attributed to mannosylphosphate (38), a mannosylphos-
phate-deficient mnn4 mutant induced normal cytokine produc-
tion. This was in agreement with the previous observation that 
this mutant is recognized normally by macrophages (28). In con-
trast, approximately 70% less cytokine production was stimulated 
by och1 mutants lacking branched N-linked mannan, and 30% 
less cytokine production was seen using a C. albicans mutant with 
truncated O-linked mannan. A similar difference in cytokine pro-
duction as found between heat-killed C. albicans strains was seen 
with the live microorganisms. This is an important observation, 
because heat-killed C. albicans was present exclusively as yeasts, 
whereas large numbers of pseudohyphae were present in the prep-
arations using live C. albicans. Therefore, mannans are the most 
important structure for the induction of cytokines by both live 
and heat-killed C. albicans, in accord with the localization of these 
epitopes at the exterior face of the fungal cell wall and with the 
modifications of the superficial cell wall structure visible by elec-
tron microscopy (Figure 1).
In addition to demonstrating the role of protein manno-
sylation for C. albicans–induced cytokine production, we also 
identified the PRRs involved in the specific recognition of 
N-linked and O-linked mannosyl residues. Using a combina-
tion of mannosyl-defective C. albicans strains, anti-receptor 
blocking antibodies, and knockout mice, we demonstrated that 
MR recognized the highly branched N-linked mannosyl chains 
whereas TLR4 bound and recognized the linear O-linked man-
nosyl chains. The role of MR (39, 40) and TLR4 (14, 22) in the 
recognition of C. albicans has already been proposed, but to our 
knowledge the C. albicans PAMPs recognized by these receptors 
have not previously been identified. We have demonstrated pre-
viously that differential activation of PRRs such as TLR2 and 
TLR4 by C. albicans activates specific responses (14, 15), and we 
and others proposed that this was a universal mechanism of 
modulation of the innate host defense (13, 41). In the present 
study we showed that the innate immune system was able to 
Figure 7
The role of N-linked mannosyl residues in virulence and in vivo cytokine 
production of C. albicans. (A) Survival of mice infected intravenously 
with 5 × 106 CFU of wild-type C. albicans, the och1 strain, or the reinte-
grant control strain. (B) Fungal burden of C. albicans in the kidneys of 
mice infected intravenously with 1 × 105 CFU of the strains described 
in A. (C) Cytokine levels on day 3 in the kidneys of mice infected with 
the strains described in A. Data are presented as means ± SD. Results 
are pooled data from 2 separate experiments with a total of 10 mice 
per group. *P < 0.05 versus wild-type.
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recognize specific structures of the fungal cell wall, and we are 
currently investigating how this recognition is translated into 
differentiated immune responses.
Using combinations of mutant C. albicans strains and receptor 
blockade (testing the och1 strain in TLR4–/– mice and the mnt1 mnt2 
strain in the presence of anti-MR antibodies), we also demonstrat-
ed that the residual cytokine production stimulated by C. albicans 
in the absence of signals mediated by mannosyl residues was medi-
ated by the β-glucan receptor dectin-1. Dectin-1 has been reported 
to be the major receptor for β-glucan (42), and recent studies have 
demonstrated that it forms a receptor complex with TLR2, ampli-
fying its effects (24, 25). Moreover, TLR2-independent activity of 
dectin-1 has also been recently reported (43). In addition, the rec-
ognition of yeasts, but not hyphae, by dectin-1 has been proposed 
to represent an escape mechanism of the fungus (31).
The differences in pattern recognition and cytokine production 
among different C. albicans strains were reflected by significant dif-
ferences in the virulence in in vivo models of disseminated candi-
diasis. In earlier studies we have demonstrated reduced virulence of 
the pmr1, och1, and mnt1 mnt2 strains (26, 27). In the present study 
we confirmed a significant reduction in the virulence of the och1 
strain and showed that this strain induced fewer cytokines in vivo 
(Figure 7). However, the experimental model of candidiasis is more 
complex than the in vitro experiments. Whereas stimulation of 
monocytes/macrophages in vitro specifically investigates the role 
of mannosyl residues for the recognition of C. albicans,	the outcome 
of the experimental infection is influenced by multiple mecha-
nisms, including pattern recognition and cytokine production as 
well as other factors such as adherence to host endothelial cells and 
growth rate of the various mutants. The och1 strain not only was 
defective in cytokine induction, as shown in the present study, but 
also displays hypersensitivity to agents that perturb the cell wall 
(29), which may be reflected in a lower resistance to candidacidal 
mechanisms. Thus a combination of these factors most likely con-
tributes to the lower virulence of the och1 C. albicans mutant.
In conclusion, we show that C. albicans induced cytokine stimula-
tion in mammalian MNCs via 3 pathways, each recognizing 1 of 
the multilayered structures of the fungal cell wall: N-linked man-
nosyl polymers are recognized by MR, O-linked chains by TLR4, 
and β-glucans by dectin-1/TLR2. Phosphomannan is apparently 
not involved in pro- or antiinflammatory cytokine induction. The 
specific activity of the cytokine induction response to these cell 
wall components reflects their abundance and accessibility in the 
C. albicans yeast cell wall. This study is the first to our knowledge 
that describes in totality the recognition pathways of a fungal 
pathogen and can serve as model for future studies of the innate 
recognition of other microorganisms.
Methods
Animals. TLR4-deficient C57BL/ScCr mice were from a local colony at Rad-
boud University Nijmegen, and control TLR4-competent C57BL/10J mice 
and C57BL/6J mice were obtained from The Jackson Laboratory. MyD88–/– 
mice and TLR2–/– mice on a C57BL/6 background were kindly provided by 
S. Akira (Tokyo University, Tokyo, Japan). All mice weighed 20–25 g and 
were 6–8 weeks old. The mice were fed sterilized laboratory chow (Hope 
Farms) and water ad libitum. The experiments were approved by the ethics 
committee on animal experiments of Radboud University Nijmegen.
C. albicans	strains and growth conditions. Homozygous null mutants in gly-
cosylation genes were constructed in the C. albicans CAI-4 serotype A back-
ground by targeted gene disruption (44). Control strains were used in which 
the wild-type genes, under the control of their own promoters, and the 
URA3 selectable marker were reintroduced at the neutral RPS1 locus via the 
CIp10 integrative plasmid (45). Parental strain CAI-4 was also transformed 
with empty CIp10, generating strain NGY152, making all strains isogenic 
with regard to Ura status. In addition, a conditional och1 mutant was also 
used in which 1 remaining functional allele was regulated by the tetracy-
cline/doxycycline–repressable TET promoter (strain NGY361; ref. 29). 
Mutants had defects in outer chain N-mannosylation (och1; strain NGY357; 
ref. 29), O-mannosylation (mnt1 mnt2; strain NGY337; ref. 27), and phos-
phomannan biosynthesis (mnn4; strain CDH15; ref. 28) or were downregu-
lated in glycosylation due to low levels of Mn2+ in the Golgi (pmr1; strain 
NGY355; ref. 26). C. albicans was grown with continuous shaking at 200 rpm 
at 30°C in Sabouraud broth (1% mycological peptone/4% glucose) over-
night, transferred to fresh medium, and incubated for 4 hours. All mutant 
strains showed similar morphology (yeasts and hyphae) to the control 
C. albicans	strain, either when incubated in growth medium or together with 
PBMCs, as described previously in detail (26–29). The cells were harvested 
by centrifugation, and the pellets were washed twice in 20 ml sterile PBS and 
resuspended to a density of 1 × 108 cells/ml before heat-killing at 56°C for 
1 hour. The TET-OCH1 strain was pregrown overnight in the presence of 
20 μg/ml doxycycline. In separate experiments, live C. albicans yeast cells were 
washed and resuspended in RPMI 1640 at a concentration of 1 × 106 CFU/ml 
and used for the stimulation of cytokine production. The mnt1 mnt2, 
och1, and pmr1 mutant strains tended to aggregate more easily in culture 
medium, and we cannot completely exclude a certain degree of aggregation 
even after disrupting them by vigorous vortexing. This may have resulted 
in some underestimation of the yeast number in the suspension containing 
these mutant strains. In contrast, the mnn4 mutant did not aggregate.
Freeze substitution TEM. Midexponential phase yeast cells were grown in 
yeast extract, peptone, and dextrose medium and harvested by centrifuga-
tion, and the pellets were resuspended in 1% agarose and transferred to flat 
specimen carriers. The samples were frozen in liquid nitrogen at high pres-
sure using a Leica EM PACT high-pressure freezer (Leica Microsystems). 
Freeze substitution of the frozen cells was carried out in an automatic tem-
perature-controlled freeze substitution system (AFS; Leica Microsystems) in 
dried acetone containing 1% OsO4 at –90°C for 48 hours. The samples were 
gradually warmed to –30°C and then processed in a Lynx tissue processor 
to finish in acetone/resin at a ratio of 1:2. The samples were transferred to a 
Lynx tissue processor to embed in TAAB812 epoxy resin (TAAB Laboratory 
Equipment Ltd.). Ultra-thin sections (60 nm) were cut with a Leica ultra-
cut E, and the sections were stained with uranyl acetate and lead citrate. 
Samples were imaged in a Philips CM10 transmission microscope (FEI UK 
Ltd.), and the images were recorded with a Gatan Bioscan 792 (Gatan).
Fungal carbohydrate polymers. The mannan from C. albicans was isolated as 
previously described by Kogan et al. (46). Briefly, 100 g wet wt of yeast bio-
mass was suspended in 400 ml 2% (wt/vol) KOH and heated for 1 hour at 
100°C. Insoluble residues were separated by centrifugation, and mannan 
was precipitated from supernatant with Fehling’s reagent. The sedimented 
mannan-copper complex was dissolved in a minimum volume of 3 M HCl 
and added dropwise to methanol/acetic acid at a ratio of 8:1 (vol/vol). The 
procedure of dissolution and precipitation was repeated twice. Finally, the 
sediment was separated, dissolved in distilled water, and dialysed for 24 
hours. Mannan contained no nitrogen as determined by elementary analysis. 
Laminarin was purchased from Sigma-Aldrich. The mannan and laminarin 
were chemically characterized to confirm their molecular weight and chemi-
cal structure (47, 48) and were assayed to confirm the absence of endotoxin.
Antibodies. The monoclonal anti-TLR4 HTA125 antibody was a kind gift 
of K. Miyake (Saga Medical School, Saga, Japan). The monoclonal mouse 
anti-human MR antibody and the isotype-matched IgG antibody used as a 
control in all experiments were purchased from Sigma-Aldrich.
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Stimulation of cytokine production in human MNCs. Isolation of MNCs was 
performed as described previously (49). Venous blood was collected from 
cubital veins of 8 healthy volunteers. All volunteers gave informed consent 
prior to participating in the study. Samples of 5 × 105 MNCs in a 100-μl 
volume were added to round-bottomed 96-well plates (Greiner Bio-One) 
and incubated for 24 hours with 100 μl of the various strains of live or 
heat-killed (30 minutes at 56°C) C. albicans at a concentration 1 × 106 yeast 
cells/ml unless otherwise indicated. In receptor-blocking studies, MNCs 
were preincubated for 1 hour at 37°C with the various monoclonal anti-
bodies (anti-TLR4, anti-MR, or control IgG; 10 μg/ml) before stimulation 
with C. albicans. After 24 hours’ incubation at 37°C, the MNC/C. albicans 
cell suspensions were centrifuged, and the supernatants were collected and 
stored at –70°C until assayed. Human TNF-α concentrations were deter-
mined by specific RIAs as described previously (50). IL-6, IL-10, and IFN-γ 
concentrations were measured by commercial ELISA kits (Sanquin).
Cytokine production by murine peritoneal macrophages. Resident peritoneal 
macrophages from the various mouse strains were harvested by injecting 
4 ml sterile PBS containing 0.38% sodium citrate (8). After centrifugation 
and washing, the cells were resuspended in RPMI 1640. Cells were cul-
tured in 96-well plates and stimulated with 100 μl of the various C. albicans 
strains for 24 hours at 37°C (50). Murine IL-1α, IL-1β, and TNF-α were 
determined by specific RIAs (detection limit, 20 pg/ml) (51).
C. albicans infection model. We used a C. albicans infection model as 
described previously (15). Briefly, 1 × 105 (for survival experiments) or 
1 × 105 CFUs (for fungal burden) of C. albicans strains (wild-type, och1, or 
the reintegrant strain) were injected i.v. into mice on day 0. Survival was 
assessed daily. On days 3, 7, and 14, kidneys and livers of subgroups of 
mice were aseptically removed, weighed, and homogenized in sterile saline 
in a tissue grinder. The number of viable C. albicans cells was determined 
by plating serial dilutions on Sabouraud dextrose agar plates. The colonies 
were counted after 24 hours at 37°C, and results were expressed as CFU/g 
tissue. In addition, tissue homogenates were centrifuged, and cytokines 
were measured in the supernatant by ELISA (see above).
Statistics. The human experiments were performed using triplicate sam-
ples in 2 experiments with a total of 8 volunteers. The mouse experiments 
were performed twice in 10 mice per group. The differences between groups 
were analyzed by Mann-Whitney U test. The level of significance between 
groups was set at P < 0.05. Data are given as means ± SD.
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